Big Gain For Minerva Neurosciences, Inc.
Thu, Aug 04, 2022 at 07:14 PM
Minerva Neurosciences, Inc. (NERV:NASDAQ) rocketted at $4.7, representing a gain of 75.4%. On Thu, Aug 04, 2022, NERV:NASDAQ hit a New 2-Week High of $4.7. From Thu, Jul 21, 2022, the stock recorded 50.00% Up Days and 54.55% Green Days
The stock spiked on Thu, Aug 04, 2022 at $7.15 with a volume of 37M+.
About Minerva Neurosciences, Inc. (NERV:NASDAQ)
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It is engaged in the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system, or CNS, diseases.
Top 10 Gainers:
- ChemoCentryx, Inc. (CCXI:NASDAQ), 109.17%
- Assure Holdings Corp. (IONM:NASDAQ), 103.88%
- Onion Global Limited American Depositary Shares (each ten (10) ADSs representing one (1) Class A) (OG:NYSE), 90.6%
- InVivo Therapeutics Holdings Corp. (NVIV:NASDAQ), 81%
- Minerva Neurosciences, Inc. (NERV:NASDAQ), 75.37%
- Cognition Therapeutics Inc. (CGTX:NASDAQ), 65.14%
- Missfresh Limited (MF:NASDAQ), 51.69%
- NanoViricides, Inc. (NNVC:NYSEMKT), 48.37%
- ChinaNet Online Holdings, Inc. (CNET:NASDAQ), 44.37%
- Yellow Corporation (YELL:NASDAQ), 42.25%